TY  - GEN
AB  - The purpose of this book is to give a concise introduction to development and analysis of pharmaceutical biologics for those in the pharmaceutical industry who are switching focus from small molecules to biologics processing, analysis, and delivery. In order to maintain a limited focus, Introduction to Biologic and Biosimilar Product Development and Analysis, will deal only with peptides, proteins and monoclonal antibodies.
AU  - Nagel, Karen,
CN  - RM301.25
DO  - 10.1007/978-3-319-98428-5
DO  - doi
ID  - 856305
KW  - Drug development.
KW  - Biologicals.
LK  - https://univsouthin.idm.oclc.org/login?url=http://link.springer.com/10.1007/978-3-319-98428-5
N2  - The purpose of this book is to give a concise introduction to development and analysis of pharmaceutical biologics for those in the pharmaceutical industry who are switching focus from small molecules to biologics processing, analysis, and delivery. In order to maintain a limited focus, Introduction to Biologic and Biosimilar Product Development and Analysis, will deal only with peptides, proteins and monoclonal antibodies.
SN  - 9783319984285
SN  - 3319984284
T1  - Introduction to biologic and biosimilar product development and analysis /
TI  - Introduction to biologic and biosimilar product development and analysis /
UR  - https://univsouthin.idm.oclc.org/login?url=http://link.springer.com/10.1007/978-3-319-98428-5
ER  -